Myomo (MYO) FCF Margin Growth (5y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6,603.00 |
| Jun 30, 2025 | 31,387.00 |
| Mar 31, 2025 | 21,608.00 |
| Dec 31, 2024 | 19,554.00 |
| Sep 30, 2024 | 35,839.00 |
| Jun 30, 2024 | 23,613.00 |
| Mar 31, 2024 | 28,847.00 |
| Dec 31, 2023 | 23,337.00 |
| Sep 30, 2023 | 37,880.00 |
| Jun 30, 2023 | 36,840.00 |
| Mar 31, 2023 | 69,006.00 |
| Dec 31, 2022 | 200,217.00 |
| Sep 30, 2022 | 31,139.00 |
| Jun 30, 2022 | 44,370.00 |
| Mar 31, 2022 | 624,142.00 |
| Dec 31, 2021 | 15,576.00 |
| Sep 30, 2021 | 66,168.00 |